Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Shohei Koide

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5473-4358; OpenAlex author ID A5026366958. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
1
Labs led
0
Collaborators
5
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 1

  1. Targeting the KRAS α4-α5 allosteric interface inhibits pancreatic cancer tumorigenesis. Co-author DOI 10.1080/21541248.2021.1906621↗

Grants 1

  1. Targeting Lipocalin 2 (LCN2) to Drive Immunotherapy Against Pancreatic Cancer AWARD stephenson:2026-shohei-koide-targeting-lipocalin-2-lcn2-to-drive-immu

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Julia E. Lefler · 1 shared paper, 2022 · strength 0.14
  2. Catherine B. MarElia · 1 shared paper, 2022 · strength 0.14
  3. Imran Khan · 1 shared paper, 2022 · strength 0.14
  4. John P O'Bryan · 1 shared paper, 2022 · strength 0.14
  5. Michael C. Ostrowski · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.